SAN DIEGO — Results from the ICON study presented at DDW demonstrated that fecal microbiota transplantation was safe and effective in patients with inflammatory bowel disease and Clostridioides difficile infection.
“C. diff is a huge problem,” Jessica R. Allegretti, MD, director of the FMT program at Brigham and Women’s Hospital, said during her presentation. “It is the most common cause of health care associated infection in the U.S. still with an estimated half a million new cases annually.”
However, as Allegretti highlighted, the incidence is even higher

Source link